ABBOTT LABORATORIES — Director's Dealing 2023

Aug 11, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2023-08-08

Reporting Person: Wainer Andrea F (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-08	Common shares without par value	M	5000	$38.40	Acquired	75427	Direct
2023-08-08	Common shares without par value	S	4741	$105	Disposed	70686	Direct
2023-08-08	Common shares without par value	S	244	$105.43	Disposed	70442	Direct
2023-08-08	Common shares without par value	S	15	$107.42	Disposed	70427	Direct
2023-08-08	Common shares without par value	S	5112	$105	Disposed	65315	Direct
2023-08-08	Common shares without par value	S	272	$105.43	Disposed	65043	Direct
2023-08-08	Common shares without par value	S	16	$107.42	Disposed	65027	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-08	Option (right to buy)	$38.40	M	5000	Disposed	2026-02-18	Common Shares (5000)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.